Influence of atorvastatin in short-term renal function and long-term cardiovascular events in patients with high risk for CIN

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2010
INTERVENTION: 1:atorvastatin 80mg;2:atorvastatin 40mg;3:atorvastatin 20mg; CONDITION: Contrast‐InducedNephropathy PRIMARY OUTCOME: alpha‐MG, mALB, TRF, Cr;CysC;hs‐CRP, Fib; SECONDARY OUTCOME: TNI, CK‐M; INCLUSION CRITERIA: PCI and the CIN risk score >=6
Epistemonikos ID: 500d8130e0778b64c5c582835ba559771ba31435
First added on: Aug 22, 2024